Table 2.
Prevalence of cancer patients with CVDs.
| All | Lung | Colorectal | Gastric | Breast | Thyroid | P | |
|---|---|---|---|---|---|---|---|
| (n = 35,681) | (n = 15,951) | (n = 6,429) | (n = 6,253) | (n = 5,677) | (n = 1,551) | ||
| CVD, N (%) | 9,018 (25.1) | 3,919 (24.6) | 1,996 (31.0) | 1,675 (26.8) | 1,048 (18.5) | 380 (24.5) | <0.001 |
| HTN, N (%) | 7,848 (21.9) | 3,390 (21.3) | 1,755 (27.3) | 1,406 (22.5) | 950 (16.7) | 347 (22.4) | <0.001 |
| CHD, N (%) | 2,320 (6.5) | 1,054 (6.6) | 461 (7.2) | 421 (6.7) | 281 (4.9) | 103 (6.6) | <0.001 |
| AF, N (%) | 1,041 (2.9) | 470 (2.9) | 263 (4.1) | 182 (2.9) | 93 (1.6) | 33 (2.1) | <0.001 |
| HF, N (%) | 345 (1.0) | 160 (1.0) | 76 (1.2) | 54 (0.9) | 45 (0.8) | 10 (0.6) | 0.110 |
HTN, hypertension; AF, atrial fibrillation; CHD, coronary heart disease; HF, heart failure.